Abstract
The aim of the present study was to describe the mutational characteristics in Korean hereditary spherocytosis(HS) patients. Relevant literatures including genetically confirmed cases with well-documented clinical summaries and relevant information was also reviewed to investigate the mutational gene- or domain-specific laboratory and clinical association. Twenty-five HS patients carried one heterozygous mutation of ANK1(n=13) or SPTB(n=12) but not in SPTA1, SLC4A1, or EPB42. Deleterious mutations including frameshift, nonsense, and splice site mutations were identified in 91%(21/23) and non-hotspot mutations were dispersed across multiple exons. Genotype-phenotype correlation was clarified after combined analysis of the cases and the literature review; anemia was most severe in HS patients with mutations on the ANK1 spectrin binding domain (P<0.05), and SPTB mutations in HS patients spared the tetramerization domain in which mutations of hereditary elliptocytosis and pyropoikilocytosis are located. Splenectomy(17/75) was more frequent in ANK1 mutant HS(32%) than in HS with SPTB mutation(10%) (P = 0.028). Aplastic crisis occurred in 32.0% of the patients(8/25; 3 ANK1 and 5 SPTB) and parvovirus B19 was detected in 88%. The study clarifies ANK1 or SPTB mutational characteristics in HS Korean patients. The genetic association of laboratory and clinical aspects suggests comprehensive considerations for genetic-based management of HS.
from Genes via ola Kala on Inoreader http://ift.tt/1NLc7pR
via IFTTT
from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1UChpJP
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου